US Stock MarketDetailed Quotes
ASLN Aslan Pharmaceuticals
- 0.6000
- 0.00000.00%
Close Jul 18 16:00 ET
1.70MMarket Cap-38P/E (TTM)
0.0000High0.0000Low0Volume0.0000Open0.6000Pre Close0.00Turnover0.00%Turnover RatioLossP/E (Static)2.83MShares16.720052wk High-0.09P/B1.49MFloat Cap0.475052wk Low--Dividend TTM2.49MShs Float417.5600Historical High--Div YieldTTM0.00%Amplitude0.4750Historical Low--Avg Price1Lot Size
Aslan Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 12M | 0 | 0 | 12M | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --12M | --0 | --0 | --12M | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Gross profit | 12M | 0 | 0 | 12M | 0 | 0 | 0 | 0 | ||
| Operating expense | -48.68%9.29M | 16.93%55.66M | -2.62%12.77M | 1.23%10.42M | 16.78%14.36M | 52.21%18.1M | 40.78%47.6M | 18.11%13.12M | 28.20%10.29M | 57.46%12.3M |
| Selling and administrative expenses | -16.10%3.4M | 33.98%13.24M | 19.85%3.25M | 37.12%3.18M | 19.30%2.77M | 59.63%4.05M | -16.43%9.88M | 24.69%2.71M | -16.24%2.32M | -38.78%2.32M |
| -General and administrative expense | -16.10%3.4M | 33.98%13.24M | 19.85%3.25M | 37.12%3.18M | 19.30%2.77M | 59.63%4.05M | -16.43%9.88M | 24.69%2.71M | -16.24%2.32M | -38.78%2.32M |
| Research and development costs | -58.06%5.9M | 11.83%42.5M | -10.15%9.6M | -9.20%7.24M | 16.19%11.6M | 50.20%14.06M | 72.56%38M | 19.20%10.69M | 51.58%7.98M | 146.78%9.98M |
| Other operating expenses | ---- | 73.46%-73.72K | ---- | ---- | ---- | ---- | -792.77%-277.76K | ---- | ---- | ---- |
| Operating profit | 48.68%-9.29M | 8.28%-43.66M | 2.62%-12.77M | -1.23%-10.42M | 80.78%-2.36M | -52.21%-18.1M | -40.78%-47.6M | -18.11%-13.12M | -28.20%-10.29M | -57.46%-12.3M |
| Net non-operating interest income expense | 11.46%-664.33K | -21.68%-3.93M | -114.71%-987.63K | -32.89%-1.13M | -26.64%-1.06M | 30.57%-750.3K | -73.43%-3.23M | 38.49%-459.99K | -70.73%-850.47K | -310.96%-835.93K |
| Non-operating interest income | -99.46%1.74K | -9.74%404.98K | -96.82%10.11K | -98.37%1.41K | 66.56%68.91K | 13,288.90%324.55K | 204,788.13%448.71K | 757,676.19%318.27K | 433,110.00%86.64K | 206,765.00%41.37K |
| Non-operating interest expense | -38.03%666.07K | 17.96%4.33M | 28.85%992.86K | 20.75%1.13M | 28.52%1.13M | -0.75%1.07M | 97.10%3.67M | 3.03%770.53K | 88.12%937.11K | 331.26%877.3K |
| Total other finance cost | ---- | -36.85%4.88K | ---- | ---- | ---- | ---- | --7.72K | ---- | ---- | ---- |
| Other net income (expense) | 114.28%36.03K | 875.58%3.5M | 134.86%287.91K | 694.39%1.87M | 1,471.98%1.6M | -773.59%-252.27K | -111.05%-451.49K | -130.42%-825.89K | 1,001.37%235.46K | -96.05%101.5K |
| Gain on sale of security | ---- | 6,530.58%3.13M | ---- | ---- | ---- | ---- | -95.73%47.27K | ---- | ---- | ---- |
| Earnings from equity interest | --0 | 98.03%-8.59K | --0 | --0 | 101.91%2.95K | 92.72%-11.53K | -7.47%-436.03K | 76.08%-45.52K | 41.48%-78.14K | -87.92%-153.87K |
| Special income (charges) | ---- | 32,925.26%387.06K | ---- | ---- | --0 | ---- | -99.97%1.17K | ---- | ---- | ---50.11K |
| -Less:Other special charges | ---- | ---386.91K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Write off | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --50.11K |
| -Gain on sale of business | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| -Gain on sale of property,plant,equipment | ---- | -87.37%148 | ---- | ---- | ---- | ---- | --1.17K | ---- | ---- | ---- |
| Other non- operating income (expenses) | 114.96%36.03K | 82.59%-11.13K | -290.12%-3.23M | 496.44%1.87M | 421.34%1.59M | -222.86%-240.74K | -8,239.49%-63.9K | 47.72%-828.82K | 191.99%313.6K | 866.46%305.48K |
| Income before tax | 48.08%-9.92M | 14.03%-44.09M | 6.45%-13.47M | 11.26%-9.68M | 85.98%-1.83M | -47.69%-19.11M | -62.34%-51.28M | -57.60%-14.4M | -27.53%-10.91M | -139.25%-13.03M |
| Income tax | 0 | 33.71%132.67K | -49.71%39.92K | 41.11%28K | 58.16K | 6.59K | 99.22K | 79.38K | 19.84K | 0 |
| Net income | 48.10%-9.92M | 13.94%-44.22M | 6.69%-13.51M | 11.17%-9.71M | 85.53%-1.89M | -47.74%-19.11M | -62.65%-51.38M | -58.47%-14.48M | -27.77%-10.93M | -139.25%-13.03M |
| Net income continuous Operations | 48.10%-9.92M | 13.94%-44.22M | 6.69%-13.51M | 11.17%-9.71M | 85.53%-1.89M | -47.74%-19.11M | -62.65%-51.38M | -58.47%-14.48M | -27.77%-10.93M | -139.25%-13.03M |
| Minority interest income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Net income attributable to the parent company | 48.10%-9.92M | 13.94%-44.22M | 6.69%-13.51M | 11.17%-9.71M | 85.53%-1.89M | -47.74%-19.11M | -64.05%-51.38M | -63.27%-14.48M | -27.77%-10.93M | -140.10%-13.03M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 48.10%-9.92M | 13.94%-44.22M | 6.69%-13.51M | 11.17%-9.71M | 85.53%-1.89M | -47.74%-19.11M | -64.05%-51.38M | -63.27%-14.48M | -27.77%-10.93M | -140.10%-13.03M |
| Basic earnings per share | 60.00%-4 | 26.67%-22 | 25.00%-6 | 33.33%-4 | 88.53%-0.9174 | -25.00%-10 | -50.00%-30 | -33.33%-8 | -50.00%-6 | -300.00%-8 |
| Diluted earnings per share | 60.00%-4 | 26.67%-22 | 25.00%-6 | 33.33%-4 | 88.53%-0.9174 | -25.00%-10 | -50.00%-30 | -33.33%-8 | -50.00%-6 | -300.00%-8 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data